Sequence-Dependent Performance Adaptations Following Myofascial Chain Training in Youth Football … (NCT07665138) | Clinical Trial Compass
CompletedNot Applicable
Sequence-Dependent Performance Adaptations Following Myofascial Chain Training in Youth Football Players
Turkey (Türkiye)40 participantsStarted 2025-05-05
Plain-language summary
This study looked at whether the order of two different types of muscle-and-connective-tissue ("myofascial chain") training affects how young football players improve their jumping power and balance.
Forty male football players, aged 15 to 16, took part. Players were split into two groups by chance. One group did "posterior chain" training first, then switched to "spiral chain" training. The other group did the trainings in the opposite order. Each training phase lasted six weeks, and players kept doing their normal team practice at the same time.
Jumping power and balance were measured four times: before training started, after the first six weeks, after the second six weeks, and again four weeks after training ended.
The goal was to find out if starting with one type of training instead of the other leads to bigger, faster, or longer-lasting improvements. This information may help coaches design better training programs for young athletes.
Who can participate
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
IInclusion Criteria:
* Male, aged 15-16 years (U15-U16 category)
* Holding an active football player license and currently competing with a club team
* Regularly participating in routine club training sessions
* Free from any injury or musculoskeletal condition that could affect performance testing at the time of enrollment
* Parental/legal guardian consent and participant assent obtained
Exclusion Criteria:
* Presence of any musculoskeletal injury, recent surgery, or medical condition affecting lower-limb function within the past 6 months
* Inability to attend the required training sessions or assessment time points
* Unwillingness or inability of parents/legal guardians to provide informed consent
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Countermovement Jump (CMJ) Height
Timeframe: Measured at baseline (pre-test), 6 weeks (mid-test), 12 weeks (post-test), and 4 weeks post-test (follow-up)